Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA
- 1 December 2013
- journal article
- review article
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 20 (6) , 969-975
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Identification of Therapeutic Benefit from Revascularization in Patients With Left Ventricular Systolic DysfunctionCirculation: Cardiovascular Imaging, 2013
- Fractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery DiseaseJACC, 2010
- Fractional Flow Reserve and Myocardial Perfusion Imaging in Patients With Angiographic Multivessel Coronary Artery DiseaseJACC: Cardiovascular Interventions, 2010
- A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery DiseaseNew England Journal of Medicine, 2009
- Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary InterventionNew England Journal of Medicine, 2009
- Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic BurdenCirculation, 2008
- Optimal Medical Therapy with or without PCI for Stable Coronary DiseaseNew England Journal of Medicine, 2007
- Meta-Analysis of Fractional Flow Reserve Versus Quantitative Coronary Angiography and Noninvasive Imaging for Evaluation of Myocardial IschemiaThe American Journal of Cardiology, 2007
- Comparison of the Short-Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed TomographyCirculation, 2003
- Task force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor managementJACC, 1996